secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001193125-25-002920
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics gets bid-price extension to July 7, 2025; transfers to Nasdaq Capital Market
--------------------------------------------------------------------------------

- Nasdaq approved transfer to Capital Market; trading under SNSE starts Jan 8, 2025.
- Received additional 180-day period until July 7, 2025 to regain $1 minimum bid compliance.
- If not compliant by July 7, Nasdaq will issue delisting notice; company may appeal but no guarantee.
- Evaluating options including reverse stock split to address bid price deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312525002920/0001193125-25-002920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312525002920/d909848d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-002920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer